Diabetes remains a major clinical challenge that generates $760 billion in global spending per year. Diagnostic testing is expected to reach $18.9 billion in 2021, a total that is likely to grow significantly in the years ahead thanks to new technological advances in diabetes testing. That is the finding of a new report from leading health care financial market analysis firm Kalorama Information. The Diabetes Testing Market Growing incidence rates have made diabetes a problem of global concern, especially in less developed countries. According to the World Health Organization (WHO), 470 million people around the world had diabetes in 2020, with deaths related to diabetes projected to increase by over 50 percent in the next 10 years. The International Diabetes Federation (IDF) estimates that annual health care spending on diabetes, which currently totals $760 billion, will likely rise to $927 billion by 2035. In addition, there are an estimated 240 million around the world whose diabetes cases have not been diagnosed, mostly in low- and middle-income countries where access to medical care is limited. But there is more to the opportunity than just the disease data and demographics; technology is also driving growth in diabetes testing. While most patients still […]